RPG Life Sciences has soared 18% to Rs 72.45 after returning to profit in the fourth quarter ended March 31, 2013.
The pharmaceutical company has reported a net profit of Rs 7.40 crore in Q4FY13, as against net loss of Rs 5.69 crore during the corresponding quarter of previous fiscal. Net sales increased by 37% to 56.34 crore from Rs 41.23 crore during the recently concluded quarter.
“The investments made in upgradation of manufacturing facility, formulation business, during the year constraining the profitability,” says Ajit Singh Chouhan, managing director of the company.
Meanwhile, the board recommends dividend at 15% of face value of Rs 1.20 per share.
The stock opened at Rs 66.30 and hit a high of Rs 73.85 on NSE. A combined 18,261 shares have changed hands on the counter till 1004 hours on NSE and BSE.
The pharmaceutical company has reported a net profit of Rs 7.40 crore in Q4FY13, as against net loss of Rs 5.69 crore during the corresponding quarter of previous fiscal. Net sales increased by 37% to 56.34 crore from Rs 41.23 crore during the recently concluded quarter.
“The investments made in upgradation of manufacturing facility, formulation business, during the year constraining the profitability,” says Ajit Singh Chouhan, managing director of the company.
Meanwhile, the board recommends dividend at 15% of face value of Rs 1.20 per share.
The stock opened at Rs 66.30 and hit a high of Rs 73.85 on NSE. A combined 18,261 shares have changed hands on the counter till 1004 hours on NSE and BSE.